FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023236412> ?p ?o ?g. }

• W2023236412 abstract "The primary objective of this meta-analytic study was to determine the impact of RSV-IGIV and palivizumab on risk of respiratory syncytial virus (RSV)-related hospitalization. Secondary objectives were to determine if antibody therapy decreases the risk of RSV infection, intensive care admission, mechanical ventilation, and mortality in high risk infant populations.We performed searches of electronic data bases from 1966 to April 2009. Inclusion and exclusion criteria were defined a priori. Inclusion criteria were as follows: 1) There was randomization between polyclonal or monoclonal antibodies and placebo or no therapy, and 2) Polyclonal or monoclonal antibodies were given as prophylaxis.Of the six included studies, three utilized RSV-IGIV (total of 533 randomized to treatment groups) and three utilized palivizumab (total of 1,663 randomized to treatment groups). The absolute risk of hospitalization in the control arms was 12% and overall RR for all 2,196 children who received one of the antibody products was 0.53 (95% CI 0.43, 0.66), P < 0.00001. When looking only at the children who received palivizumab, the RR for hospitalization was 0.50 (95% CI 0.38, 0.66), P < 0.00001. For the children receiving RSV-IGIV, the RR for hospitalization was 0.59 (95% CI 0.42, 0.83, P < 0.002). The use of palivizumab resulted in a significant decrease in admission to the ICU (RR 0.29 (95% CI 0.14, 0.59; P = 0.0007). There was no significant reduction in the risk of mechanical ventilation or mortality with the use of antibody prophylaxis. Infants born at less than 35 weeks gestational age, and those with chronic lung and congenital heart disease all had a significant reduction in the risk of RSV hospitalization with children born under 35 weeks gestational age showing a trend towards the greatest benefit.Both palivizumab and RSV-IGIV decrease the incidence of RSV hospitalization and ICU admission and their effect appears to be qualitatively similarly. There was neither a statistically significant reduction in the incidence of mechanical ventilation nor in all cause mortality. This meta-analysis separately quantifies the impact of RSV-IGIV and palivizumab on various measures of severe RSV disease and builds upon a previous study that was only able to examine the pooled effect of all antibody products together." @default.
• W2023236412 created "2016-06-24" @default.
• W2023236412 creator A5005916952 @default.
• W2023236412 creator A5025440466 @default.
• W2023236412 creator A5027743498 @default.
• W2023236412 creator A5086900250 @default.
• W2023236412 date "2009-07-05" @default.
• W2023236412 modified "2023-10-13" @default.
• W2023236412 title "A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection" @default.
• W2023236412 cites W1966099212 @default.
• W2023236412 cites W1986215651 @default.
• W2023236412 cites W2000442546 @default.
• W2023236412 cites W2013659785 @default.
• W2023236412 cites W2029503764 @default.
• W2023236412 cites W2036877259 @default.
• W2023236412 cites W2084584261 @default.
• W2023236412 cites W2088783942 @default.
• W2023236412 cites W2093529351 @default.
• W2023236412 cites W2107328434 @default.
• W2023236412 cites W2125435699 @default.
• W2023236412 cites W2164777277 @default.
• W2023236412 cites W2328116798 @default.
• W2023236412 cites W4245170709 @default.
• W2023236412 cites W4255267202 @default.
• W2023236412 cites W4292315834 @default.
• W2023236412 doi "https://doi.org/10.1186/1471-2334-9-106" @default.
• W2023236412 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2720977" @default.
• W2023236412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19575815" @default.
• W2023236412 hasPublicationYear "2009" @default.
• W2023236412 type Work @default.
• W2023236412 sameAs 2023236412 @default.
• W2023236412 citedByCount "42" @default.
• W2023236412 countsByYear W20232364122012 @default.
• W2023236412 countsByYear W20232364122013 @default.
• W2023236412 countsByYear W20232364122014 @default.
• W2023236412 countsByYear W20232364122015 @default.
• W2023236412 countsByYear W20232364122016 @default.
• W2023236412 countsByYear W20232364122017 @default.
• W2023236412 countsByYear W20232364122018 @default.
• W2023236412 countsByYear W20232364122020 @default.
• W2023236412 countsByYear W20232364122021 @default.
• W2023236412 countsByYear W20232364122022 @default.
• W2023236412 countsByYear W20232364122023 @default.
• W2023236412 crossrefType "journal-article" @default.
• W2023236412 hasAuthorship W2023236412A5005916952 @default.
• W2023236412 hasAuthorship W2023236412A5025440466 @default.
• W2023236412 hasAuthorship W2023236412A5027743498 @default.
• W2023236412 hasAuthorship W2023236412A5086900250 @default.
• W2023236412 hasBestOaLocation W20232364121 @default.
• W2023236412 hasConcept C126322002 @default.
• W2023236412 hasConcept C142724271 @default.
• W2023236412 hasConcept C168563851 @default.
• W2023236412 hasConcept C187212893 @default.
• W2023236412 hasConcept C204787440 @default.
• W2023236412 hasConcept C27081682 @default.
• W2023236412 hasConcept C2777080012 @default.
• W2023236412 hasConcept C2778644256 @default.
• W2023236412 hasConcept C44249647 @default.
• W2023236412 hasConcept C534529494 @default.
• W2023236412 hasConcept C71924100 @default.
• W2023236412 hasConcept C82789193 @default.
• W2023236412 hasConceptScore W2023236412C126322002 @default.
• W2023236412 hasConceptScore W2023236412C142724271 @default.
• W2023236412 hasConceptScore W2023236412C168563851 @default.
• W2023236412 hasConceptScore W2023236412C187212893 @default.
• W2023236412 hasConceptScore W2023236412C204787440 @default.
• W2023236412 hasConceptScore W2023236412C27081682 @default.
• W2023236412 hasConceptScore W2023236412C2777080012 @default.
• W2023236412 hasConceptScore W2023236412C2778644256 @default.
• W2023236412 hasConceptScore W2023236412C44249647 @default.
• W2023236412 hasConceptScore W2023236412C534529494 @default.
• W2023236412 hasConceptScore W2023236412C71924100 @default.
• W2023236412 hasConceptScore W2023236412C82789193 @default.
• W2023236412 hasIssue "1" @default.
• W2023236412 hasLocation W20232364121 @default.
• W2023236412 hasLocation W20232364122 @default.
• W2023236412 hasLocation W20232364123 @default.
• W2023236412 hasLocation W20232364124 @default.
• W2023236412 hasLocation W20232364125 @default.
• W2023236412 hasOpenAccess W2023236412 @default.
• W2023236412 hasPrimaryLocation W20232364121 @default.
• W2023236412 hasRelatedWork W1490319104 @default.
• W2023236412 hasRelatedWork W1521115986 @default.
• W2023236412 hasRelatedWork W2009097124 @default.
• W2023236412 hasRelatedWork W2065566745 @default.
• W2023236412 hasRelatedWork W2314642553 @default.
• W2023236412 hasRelatedWork W2592183814 @default.
• W2023236412 hasRelatedWork W2883825446 @default.
• W2023236412 hasRelatedWork W2906030035 @default.
• W2023236412 hasRelatedWork W3112645849 @default.
• W2023236412 hasRelatedWork W7127250 @default.
• W2023236412 hasVolume "9" @default.
• W2023236412 isParatext "false" @default.
• W2023236412 isRetracted "false" @default.
• W2023236412 magId "2023236412" @default.
• W2023236412 workType "article" @default.